| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jul 27, 2010IMPROVE HFStudy Published in Circulation Demonstrates Improved Adherence to Five of Seven Guideline-Recommended Care Measures
MINNEAPOLIS, Jul 26, 2010 (BUSINESS WIRE) -- Results of the largest U.S. outpatient heart failure clinical study show that implementation of a process improvement program significantly improved...
-
Jul 27, 2010New biologic bone graft product demonstrated superior fusion rates compared to current standard of care for complex fusion procedures of the lower spine in the pivotal clinical trial
MINNEAPOLIS, Jul 27, 2010 (BUSINESS WIRE) -- The U.S. Food and Drug Administration (FDA) Orthopaedic and Rehabilitation Devices Panel today voted 9 for and 4 against (1 abstention) on safety and...
-
Jul 13, 2010Release Your Potential Campaign Encourages People to Take Control of Severe Spasticity and Seek Treatment
MINNEAPOLIS, Jul 13, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the launch of an educational campaign, called Release Your PotentialSM, that is designed to raise awareness...
-
Jul 2, 2010
MINNEAPOLIS, Jul 02, 2010 (BUSINESS WIRE) -- Physio-Control, Inc., a wholly owned subsidiary of Medtronic, Inc., (NYSE: MDT), announced the company's recent initiation of a field correction on...
-
Jun 30, 2010New Option in Second-Generation Pacing System Available in Select European Geographies Features Exclusive Technology and Allows Access to Critical Diagnostic Tool
MINNEAPOLIS, Jun 30, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today the company received CE (Conformité Européenne) Mark for Ensura MRI(TM) SureScan(TM) pacing system....
-
Jun 29, 2010Results of Study Published in NEJM and Presented at ADA Could Redefine the Standard of Care for People with Type 1 Diabetes
MINNEAPOLIS, Jun 29, 2010 (BUSINESS WIRE) -- In the longest and largest randomized, controlled study of sensor-augmented insulin pump therapy in type 1 diabetes, adult and pediatric patients using...
-
Jun 25, 2010Semi-Closed Loop System Designed to Reduce Severity and Duration of Hypoglycemia
MINNEAPOLIS, Jun 25, 2010 (BUSINESS WIRE) --Demonstrating its dedication to close the loop for diabetes management, Medtronic, Inc. (NYSE:MDT) today announced that the first patient has been...
-
Jun 25, 2010New Surgical Drill Offers Power and Maneuverability with Easy Fingertip Control
MINNEAPOLIS, Jun 25, 2010 (BUSINESS WIRE) --Medtronic, Inc.(NYSE: MDT) today announced availability of the company's new Midas Rex(R) Legend(R) EHS Stylus Touch(TM) high-speed electric drill for...
-
Jun 24, 2010
MINNEAPOLIS, Jun 24, 2010 (BUSINESS WIRE) --The board of directors of Medtronic, Inc. (NYSE:MDT), today approved a cash dividend of $0.225 per share of the company's common stock; an increase of 9...
-
Jun 23, 2010
MINNEAPOLIS, Jun 23, 2010 (BUSINESS WIRE) --Gary Ellis, senior vice-president and chief financial officer at Medtronic, Inc. (NYSE: MDT) today reiterated fiscal year 2011 revenue and diluted...
-
Jun 22, 2010Distance Runners from Around the World Who Benefit from Medical Technology to Run this Fall in Medtronic Twin Cities Marathon Events
MINNEAPOLIS, Jun 22, 2010 (BUSINESS WIRE) --Twenty-five long-distance runners who benefit from medical technology have been selected as 2010 Global Heroes by Twin Cities In Motion, the non-profit...
-
Jun 21, 2010
MINNEAPOLIS, Jun 21, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE:MDT) today announced the launch of KYPHON ActivOs 10 Bone Cement with Hydroxyapatite, a polymethylmethacrylate (PMMA) bone cement...
-
Jun 18, 2010Data from FAST-PVI Study Presented at Cardiostim 2010
MINNEAPOLIS, & NICE, France, Jun 18, 2010 (BUSINESS WIRE) --Data from the FAST-PVI study, supported by Medtronic, Inc. (NYSE: MDT), shows lab time using anatomically-designed ablation catheters...
-
Jun 17, 2010New Data Released at Cardiostim 2010 Shows Benefits of Advanced Shock Reduction Technologies
MINNEAPOLIS & NICE, France, Jun 17, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE:MDT) today announced European launch of the Protecta(TM)portfolio of implantable cardioverter-defibrillators (ICDs)...
-
Jun 17, 2010
MINNEAPOLIS, Jun 17, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Wells Fargo Securities 2010...
-
Jun 10, 2010
MINNEAPOLIS, Jun 10, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the 31st Annual Healthcare...
-
Jun 10, 2010
MINNEAPOLIS, Jun 10, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the William Blair Growth Stock...
-
Jun 7, 2010iPro(TM)2 Professional CGM Provides Simple Way to Reveal Insights Into Glucose Control Not Possible With Standard Glucose Assessment Methods
MINNEAPOLIS, Jun 07, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE:MDT) announced today the launch of iPro(TM)2 Professional CGM, a continuous glucose monitoring (CGM) system used by physicians to...
-
Jun 2, 2010
MINNEAPOLIS, Jun 02, 2010 (BUSINESS WIRE) --In the largest, randomized, controlled study of deep brain stimulation (DBS) for Parkinson's disease, Medtronic DBS Therapy was shown to improve motor...
-
May 30, 2010Clinical Trial of Surgical Tissue Ablation Includes Two U.S. IDE Studies
MINNEAPOLIS, May 03, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT), today announced completion of patient enrollment in the first of two studies in the company's CURE-AF (Concomitant...
-
May 26, 2010Medtronic CoreValve(R) System Shows Long-Term Efficacy and Durability in Pivotal Trial
PARIS, May 26, 2010 (BUSINESS WIRE) --New clinical data presented today at EuroPCR demonstrate positive long-term performance and durability for the CoreValve transcatheter aortic valve...
-
May 25, 2010International Revenue Growth of 20 Percent
MINNEAPOLIS, May 25, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT): First $4 Billion Sales Quarter in Company History Full Year Revenue of $15.8 Billion Increased 8 Percent Full Year Non-GAAP...
-
May 25, 2010Data Demonstrates That Revolutionary Treatment for Patients with Diseased Heart Valves Is Transitioning Successfully into Standard Clinical Practice throughout Europe
PARIS, May 25, 2010 (BUSINESS WIRE) --New European data from five national clinical registries presented today at EuroPCR report positive clinical outcomes for one of the most exciting emerging...
-
May 25, 2010One-Year Clinical Results from Innovative RESOLUTE All Comers Trial Show Excellent Performance for Resolute DES in Challenging Patient Population
PARIS, May 25, 2010 (BUSINESS WIRE) --The highly anticipated first results of the RESOLUTE All Comers study were presented today during the late-breaking clinical trial session of the 2010 EuroPCR...
-
May 20, 2010Medtronic Institutional Investor and Analyst Meeting Scheduled for Monday, June 7, 2010, 10 a.m. - 2:30 p.m. Eastern
MINNEAPOLIS, May 20, 2010 (BUSINESS WIRE) --Medtronic (NYSE: MDT) will host an institutional investor and analyst meeting on Monday, June 7, 2010, in New York City from 10 a.m. - 2:30 p.m. Eastern...